112 related articles for article (PubMed ID: 1316968)
1. Reversible inhibitors of the gastric (H+/K+)-ATPase. 2. 1-Arylpyrrolo[3,2-c]quinolines: effect of the 4-substituent.
Leach CA; Brown TH; Ife RJ; Keeling DJ; Laing SM; Parsons ME; Price CA; Wiggall KJ
J Med Chem; 1992 May; 35(10):1845-52. PubMed ID: 1316968
[TBL] [Abstract][Full Text] [Related]
2. Reversible inhibitors of the gastric (H+/K+)-ATPase. 1. 1-Aryl-4-methylpyrrolo[3,2-c]quinolines as conformationally restrained analogues of 4-(arylamino)quinolines.
Brown TH; Ife RJ; Keeling DJ; Laing SM; Leach CA; Parsons ME; Price CA; Reavill DR; Wiggall KJ
J Med Chem; 1990 Feb; 33(2):527-33. PubMed ID: 2153816
[TBL] [Abstract][Full Text] [Related]
3. Properties of the reversible, K(+)-competitive inhibitor of the gastric (H+/K+)-ATPase, SK&F 97574. II. Pharmacological properties.
Parsons ME; Rushant B; Rasmussen TC; Leach C; Ife RJ; Postius S; Pope AJ
Biochem Pharmacol; 1995 Nov; 50(10):1551-6. PubMed ID: 7503756
[TBL] [Abstract][Full Text] [Related]
4. Reversible inhibitors of the gastric (H+/K+)-ATPase. 3. 3-substituted-4-(phenylamino)quinolines.
Ife RJ; Brown TH; Keeling DJ; Leach CA; Meeson ML; Parsons ME; Reavill DR; Theobald CJ; Wiggall KJ
J Med Chem; 1992 Sep; 35(18):3413-22. PubMed ID: 1326634
[TBL] [Abstract][Full Text] [Related]
5. SK&F 96067 is a reversible, lumenally acting inhibitor of the gastric (H+ + K+)-ATPase.
Keeling DJ; Malcolm RC; Laing SM; Ife RJ; Leach CA
Biochem Pharmacol; 1991 Jun; 42(1):123-30. PubMed ID: 1648919
[TBL] [Abstract][Full Text] [Related]
6. Properties of the reversible K(+)-competitive inhibitor of the gastric (H+/K+)-ATPase, SK&F 97574. I. In vitro activity.
Pope AJ; Boehm MK; Leach C; Ife RJ; Keeling D; Parsons ME
Biochem Pharmacol; 1995 Nov; 50(10):1543-9. PubMed ID: 7503755
[TBL] [Abstract][Full Text] [Related]
7. AHR-9294: a novel inhibitor of H,K-ATPase antagonizes gastric HCl secretion in vivo.
Reenstra WW; Pinkus LM; Bailey J; Smith WL; Droppleman D; Sancilio LF; Forte JG
J Pharmacol Exp Ther; 1992 May; 261(2):737-45. PubMed ID: 1315865
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and structure-activity relationships of N-substituted 2-[(2-imidazolylsulfinyl)methyl]anilines as a new class of gastric H+/K(+)-ATPase inhibitors.
Yamakawa T; Matsukura H; Nomura Y; Yoshioka M; Masaki M; Igata H; Okabe S
Chem Pharm Bull (Tokyo); 1991 Jul; 39(7):1746-52. PubMed ID: 1663837
[TBL] [Abstract][Full Text] [Related]
9. Reversible inhibitors of the gastric (H+/K+)-ATPase. 5. Substituted 2,4-diaminoquinazolines and thienopyrimidines.
Ife RJ; Brown TH; Blurton P; Keeling DJ; Leach CA; Meeson ML; Parsons ME; Theobald CJ
J Med Chem; 1995 Jul; 38(14):2763-73. PubMed ID: 7629814
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of 4-(phenylamino)quinoline-3-carboxamides as a novel class of gastric H+/K+-ATPase inhibitors.
Uchida M; Otsubo K; Matsubara J; Ohtani T; Morita S; Yamasaki K
Chem Pharm Bull (Tokyo); 1995 Apr; 43(4):693-8. PubMed ID: 7600619
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of gastric H+/K+-ATPase by substituted imidazo[1,2-a]pyridines.
Briving C; Andersson BM; Nordberg P; Wallmark B
Biochim Biophys Acta; 1988 Dec; 946(2):185-92. PubMed ID: 2850003
[TBL] [Abstract][Full Text] [Related]
12. Interaction of the anti-inflammatory seleno-organic compound ebselen with acid secretion in isolated parietal cells and gastric H+/K(+)-ATPase.
Beil W; Staar U; Sewing KF
Biochem Pharmacol; 1990 Nov; 40(9):1997-2003. PubMed ID: 2173597
[TBL] [Abstract][Full Text] [Related]
13. (+)-Curcuphenol and dehydrocurcuphenol, novel sesquiterpenes which inhibit H,K-ATPase, from a marine sponge Epipolasis sp.
Fusetani N; Sugano M; Matsunaga S; Hashimoto K
Experientia; 1987 Dec; 43(11-12):1234-5. PubMed ID: 2826218
[TBL] [Abstract][Full Text] [Related]
14. By 1023/SK&F 96022: biochemistry of a novel (H+ + K+)-ATPase inhibitor.
Simon WA; Keeling DJ; Laing SM; Fallowfield C; Taylor AG
Biochem Pharmacol; 1990 Jun; 39(11):1799-806. PubMed ID: 2160820
[TBL] [Abstract][Full Text] [Related]
15. A model of reversible inhibitors in the gastric H+/K+-ATPase binding site determined by rotational echo double resonance NMR.
Watts JA; Watts A; Middleton DA
J Biol Chem; 2001 Nov; 276(46):43197-204. PubMed ID: 11479301
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of gastric (H+ + K+)-ATPase by unsaturated long-chain fatty acids.
Im WB; Blakeman DP
Biochim Biophys Acta; 1982 Nov; 692(3):355-60. PubMed ID: 6293567
[TBL] [Abstract][Full Text] [Related]
17. Mimicking of K+ activation by double mutation of glutamate 795 and glutamate 820 of gastric H+,K+-ATPase.
Hermsen HP; Swarts HG; Wassink L; Koenderink JB; Willems PH; De Pont JJ
Biochemistry; 2001 May; 40(21):6527-33. PubMed ID: 11371216
[TBL] [Abstract][Full Text] [Related]
18. A substituted thieno[3.4-d]imidazole versus substituted benzimidazoles as H+, K+-ATPase inhibitors.
Herling AW; Bickel M; Lang HJ; Weidmann K; Rösner M; Metzger H; Rippel R; Nimmesgern H; Scheunemann KH
Pharmacology; 1988; 36(5):289-97. PubMed ID: 2841691
[TBL] [Abstract][Full Text] [Related]
19. The mechanism and structure of the gastric H,K-ATPase.
Rabon EC; Reuben MA
Annu Rev Physiol; 1990; 52():321-44. PubMed ID: 2158765
[No Abstract] [Full Text] [Related]
20. Discovery, synthesis, and biological evaluation of novel pyrrole derivatives as highly selective potassium-competitive acid blockers.
Nishida H; Hasuoka A; Arikawa Y; Kurasawa O; Hirase K; Inatomi N; Hori Y; Sato F; Tarui N; Imanishi A; Kondo M; Takagi T; Kajino M
Bioorg Med Chem; 2012 Jun; 20(12):3925-38. PubMed ID: 22579619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
